806.53
price down icon0.39%   -2.4327
 
loading
Precedente Chiudi:
$808.96
Aprire:
$806.93
Volume 24 ore:
1.13M
Relative Volume:
0.25
Capitalizzazione di mercato:
$763.45B
Reddito:
$53.26B
Utile/perdita netta:
$13.80B
Rapporto P/E:
53.48
EPS:
15.0808
Flusso di cassa netto:
$-50.20M
1 W Prestazione:
-0.81%
1M Prestazione:
+7.16%
6M Prestazione:
-1.49%
1 anno Prestazione:
-11.07%
Intervallo 1D:
Value
$803.23
$812.99
Intervallo di 1 settimana:
Value
$783.85
$834.70
Portata 52W:
Value
$623.78
$935.62

Lilly Eli Co Stock (LLY) Company Profile

Name
Nome
Lilly Eli Co
Name
Telefono
(317) 276-2000
Name
Indirizzo
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Name
Dipendente
47,000
Name
Cinguettio
@LillyPad
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
LLY's Discussions on Twitter

Confronta LLY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
LLY
Lilly Eli Co
806.63 725.20B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
192.41 466.54B 92.15B 25.12B 18.18B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.40 409.95B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
131.06 255.13B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.26 215.61B 63.43B 16.42B 14.72B 6.4861

Lilly Eli Co Stock (LLY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-14 Aggiornamento Erste Group Hold → Buy
2025-09-17 Downgrade Berenberg Buy → Hold
2025-08-27 Aggiornamento HSBC Securities Reduce → Hold
2025-08-18 Downgrade Daiwa Securities Outperform → Neutral
2025-08-07 Downgrade Leerink Partners Outperform → Market Perform
2025-06-05 Downgrade Erste Group Buy → Hold
2025-04-28 Downgrade HSBC Securities Buy → Reduce
2025-04-22 Iniziato Cantor Fitzgerald Overweight
2024-12-10 Ripresa BofA Securities Buy
2024-11-15 Iniziato Wolfe Research Outperform
2024-10-17 Iniziato Bernstein Outperform
2024-09-13 Ripresa Citigroup Buy
2024-08-12 Aggiornamento Deutsche Bank Hold → Buy
2024-02-21 Downgrade DZ Bank Buy → Hold
2024-02-16 Reiterato Morgan Stanley Overweight
2023-12-21 Downgrade Daiwa Securities Buy → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-10-20 Ripresa UBS Buy
2023-08-09 Aggiornamento Jefferies Hold → Buy
2023-07-26 Reiterato Citigroup Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-05-24 Reiterato BofA Securities Buy
2023-05-24 Reiterato UBS Buy
2023-03-13 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-03-06 Iniziato Jefferies Hold
2023-02-15 Downgrade Societe Generale Hold → Sell
2022-11-18 Iniziato Credit Suisse Outperform
2022-09-22 Aggiornamento UBS Neutral → Buy
2022-05-23 Iniziato SVB Leerink Outperform
2022-04-06 Ripresa Morgan Stanley Overweight
2022-03-10 Iniziato Daiwa Securities Outperform
2022-01-21 Aggiornamento DZ Bank Hold → Buy
2022-01-03 Reiterato Bernstein Mkt Perform
2021-12-17 Iniziato Goldman Neutral
2021-12-16 Reiterato BMO Capital Markets Outperform
2021-12-16 Reiterato BofA Securities Buy
2021-12-09 Ripresa Wells Fargo Equal Weight
2021-11-19 Iniziato BMO Capital Markets Outperform
2021-10-11 Aggiornamento Berenberg Hold → Buy
2021-09-29 Aggiornamento Citigroup Neutral → Buy
2021-08-05 Aggiornamento DZ Bank Hold → Buy
2021-07-27 Ripresa Truist Buy
2021-06-24 Reiterato Cantor Fitzgerald Overweight
2021-01-19 Aggiornamento Mizuho Neutral → Buy
2020-12-10 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-11-10 Ripresa Bernstein Mkt Perform
2020-09-29 Iniziato Berenberg Hold
2020-09-03 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-06-16 Aggiornamento Guggenheim Neutral → Buy
2020-04-21 Downgrade UBS Buy → Neutral
2020-04-09 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-06 Iniziato Mizuho Neutral
2019-12-18 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-10-17 Ripresa BofA/Merrill Buy
2019-05-28 Iniziato Goldman Buy
2019-04-24 Aggiornamento Edward Jones Hold → Buy
2019-04-11 Downgrade Guggenheim Buy → Neutral
2019-03-12 Iniziato JP Morgan Overweight
2019-01-23 Iniziato UBS Buy
2018-11-26 Downgrade Citigroup Buy → Neutral
2018-10-31 Aggiornamento Credit Suisse Underperform → Neutral
2018-10-09 Iniziato Guggenheim Buy
2018-10-01 Reiterato SunTrust Buy
2018-09-26 Ripresa JP Morgan Overweight
Mostra tutto

Lilly Eli Co Borsa (LLY) Ultime notizie

pulisher
12:33 PM

Eli Lilly’s New Asthma Treatment Study: What Investors Need to Know - TipRanks

12:33 PM
pulisher
12:00 PM

Eli Lilly Vs Novo Nordisk: One To Walk Away From And One To Run Away From (NYSE:LLY) - Seeking Alpha

12:00 PM
pulisher
09:52 AM

Bank of America Securities Sticks to Their Buy Rating for Eli Lilly & Co (LLY) - The Globe and Mail

09:52 AM
pulisher
08:38 AM

Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100 - 富途牛牛

08:38 AM
pulisher
08:32 AM

Eli Lilly & Co: Strategic Positioning and Clinical Advancements Drive Buy Rating - TipRanks

08:32 AM
pulisher
07:28 AM

What Eli Lilly (LLY)'s Drug Pricing Pressure Means for the Future of Its Obesity Franchise - simplywall.st

07:28 AM
pulisher
05:31 AM

Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? - AOL.com

05:31 AM
pulisher
Oct 20, 2025

Eli Lilly doubles Seaport footprint with new lease, taking entire building at 645 Summer St - The Business Journals

Oct 20, 2025
pulisher
Oct 20, 2025

Coinbase CEO’s Longevity Startup Raises $45M From Eli Lilly & Others - Athletech News

Oct 20, 2025
pulisher
Oct 20, 2025

Can Eli Lilly and Company (Common Stock) (LLY0) stock survive global slowdown2025 Technical Overview & Community Consensus Trade Alerts - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Eli Lilly Q3 earnings eyed for insights into drug pricing policies - Proactive financial news

Oct 20, 2025
pulisher
Oct 20, 2025

BofA Securities Maintains Eli Lilly and Co(LLY.US) With Buy Rating - 富途牛牛

Oct 20, 2025
pulisher
Oct 20, 2025

Eli Lilly stock price target raised to $930 by BMO on incretin growth - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

Rumors of Eli Lilly buyout sends Nektar’s shares spiking - PharmaLive

Oct 20, 2025
pulisher
Oct 20, 2025

Eli Lilly Corp. buy BMO Capital Markets - sharewise.com

Oct 20, 2025
pulisher
Oct 20, 2025

Weight Loss Drugs Market Set to Reach USD 50.26 Billion by 2032, Driven by Prescription Drug Adoption and Breakthrough Formulations – SNS Insider - GlobeNewswire Inc.

Oct 20, 2025
pulisher
Oct 20, 2025

Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking - BioSpace

Oct 20, 2025
pulisher
Oct 20, 2025

BMO Capital Adjusts Price Target on Eli Lilly to $930 From $840, Maintains Outperform Rating - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Eli Lilly reports positive Phase 3 results for orforglipron in type 2 diabetes trials - Express Pharma

Oct 20, 2025
pulisher
Oct 20, 2025

Anti-aging biotech NewLimit brings in Eli Lilly as investor, raising $45M - Endpoints News

Oct 20, 2025
pulisher
Oct 19, 2025

J.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears - The Motley Fool

Oct 19, 2025
pulisher
Oct 18, 2025

Why Eli Lilly and Company stock remains on buy lists2025 Key Highlights & Trade Opportunity Analysis - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Can Eli Lilly and Company stock surprise with quarterly resultsTrade Volume Report & Weekly High Return Stock Forecasts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Can Eli Lilly and Company (LLY) stock reach $200 price targetNew Guidance & Target Return Focused Stock Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Major Stock Moves: Eli Lilly, Delta, Caterpillar, Dell, CoreWeave - TipRanks

Oct 18, 2025
pulisher
Oct 17, 2025

Can Eli Lilly and Company stock withstand economic slowdownJuly 2025 Levels & Fast Entry and Exit Trade Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

3 Price Catalysts For Eli Lilly (NYSE:LLY) - Seeking Alpha

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly (LLY) Reports Positive Results from Breast Cancer Trial - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Stock Movers: Oracle, American Express, Eli Lilly - Bloomberg.com

Oct 17, 2025
pulisher
Oct 17, 2025

Why Eli Lilly (LLY) Stock Is Down Today - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly (LLY) Shares Drop Due to Recent Voucher Snub and Compe - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly falls on orforglipron FDA voucher exclusion, Trump on weight-loss meds - Seeking Alpha

Oct 17, 2025
pulisher
Oct 17, 2025

Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks - MSN

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly Shares Are Trading Lower Friday: What's Going On? - Benzinga

Oct 17, 2025
pulisher
Oct 17, 2025

Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price - Bloomberg.com

Oct 17, 2025
pulisher
Oct 17, 2025

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? - Benzinga

Oct 17, 2025
pulisher
Oct 17, 2025

Market Jitters: Dow Dips Amid Bank Fears While Eli Lilly and Novo Nordisk Tumble on Trump's Drug Pricing Comments - FinancialContent

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly and Company Stock (LLY) Opinions on Drug Pricing Initiative - Quiver Quantitative

Oct 17, 2025
pulisher
Oct 17, 2025

Novo, Lilly Shares Drop as Trump Promises $150 Ozempic - BioSpace

Oct 17, 2025
pulisher
Oct 17, 2025

Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Lilly CSO defends hiring of ex-FDA chief Peter Marks - statnews.com

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly, Novo Nordisk Tumbles After Trump Says Weight-Loss Drugs Are 'Too Expensive' - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Novo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug prices - Proactive financial news

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly (LLY) Reports Promising Results from Phase 3 monarchE Trial - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly Sets Ambitious Sustainability Goals Despite Headwinds - Investor's Business Daily

Oct 17, 2025
pulisher
Oct 17, 2025

Cantor Fitzgerald maintains Eli Lilly stock rating despite orforglipron setback - Investing.com

Oct 17, 2025
pulisher
Oct 17, 2025

Novo Nordisk, Eli Lilly shares drop as Trump vows weight-loss drug price cuts - Yahoo

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly Says Verzenio Reduced Risk of Death In Late-Stage Trial In Some Breast Cancer Patients - Stocktwits

Oct 17, 2025
pulisher
Oct 17, 2025

The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics - sharewise.com

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly reports results from Phase 3 monarchE trial - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug - Investor's Business Daily

Oct 17, 2025

Lilly Eli Co Azioni (LLY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general JNJ
$192.33
price down icon 0.72%
$231.26
price down icon 0.35%
drug_manufacturers_general NVS
$131.00
price down icon 0.63%
drug_manufacturers_general MRK
$87.22
price up icon 1.07%
drug_manufacturers_general NVO
$54.84
price down icon 1.61%
Capitalizzazione:     |  Volume (24 ore):